Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy
Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Subjects
More information
Scope and Contents
Contents
ObjectivesN-terminal probrain natriuretic peptide (NT-proBNP) predicts mortality and the development of heart failure in hypertrophic cardiomyopathy (HCM). Mid-regional proatrial natriuretic peptide (MR-proANP) is a stable by-product of production of atrial natriuretic peptide. We sought to compare the prognostic value of MR-proANP and NT-proBNP in...
Alternative Titles
Full title
Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_umu_168136
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_umu_168136
Other Identifiers
ISSN
1355-6037,1468-201X
E-ISSN
1468-201X
DOI
10.1136/heartjnl-2019-314826
